Treatment of uveal melanoma by accelerated proton beam

Developments in Ophthalmology

Volumn 49, Issue , 2012, Pages 41-57

  Desjardins, Laurence ^a   Lumbroso Le Rouic, Livia ^a   Levy Gabriel, Christine ^a   Cassoux, Nathalie ^a   Dendale, Remi ^a   Mazal, Alexandro ^a   Delacroix, Sabine ^a   Sastre, Xavier ^a   Plancher, Corine ^a   Asselain, Bernard ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON;

ARTICLE; HUMAN; MELANOMA; RADIATION RESPONSE; TREATMENT OUTCOME; UVEA MELANOMA; UVEA TUMOR;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MELANOMA; PROTONS; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 84875242672     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000328257     Document Type: Article

References (58)

1. Stallard HB: Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 1966;50:147-155.
2. Zimmerman L, McLean I, Foster W: Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells ? Br J Ophthalmol 1978;62:420-425.
3. Gragoudas ES, Seddon JM, Egan K, et al: Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987;94:349-353.
4. Gragoudas E, Seddon J, Egan K, et al: Proton Irradiation of Uveal Melanomas: The First 1,000 Patients. Amsterdam, Kugler Publications, 1991.
5. Gragoudas ES, Goitein M, Verhey L, Munzenreider J, Suit HD, Koehler A: Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology 1980;87:571-581.
6. Zografos L, Bercher L, Egger E, et al: Treatment of eye tumors by accelerated proton beams. 7 years experience. Klin Monatsbl Augenheilkd 1992;200: 431-435.
7. Desjardins L, Levy C, d'Hermies F, et al: Initial results of proton therapy in choroidal melanoma at the d'Orsey Center for Proton Therapy; the first 464 cases. Cancer Radiother 1997;1:222-226.
8. Nauraye C, Mazal A, Delacroix S, Bridier A, Chavaudra J, Rosenwald JC: An experimental approach to the design of a scattering system for a proton therapy beam line dedicated to ophthalmological applications. Int J Radiat Oncol Biol Phys 1995;32:1177-1183.
9. Hocht S, Bechrakis NE, Nausner M, et al: Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Strahlenther Onkol 2004;180:419-424.
10. Spatola C, Privitera G, Raffaele L, et al: Clinical application of proton beams in the treatment of uveal melanoma: The first therapies carried out in Italy and preliminary results (CATANA Project). Tumori 2003;89:502-509.
11. Weber DC, Bogner J, Verwey J, et al: Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys 2005;63:373-384.
12. Gragoudas ES: The Bragg peak of proton beams for treatment of uveal melanoma. Int Ophthalmol Clin 1980;20:123-133.
13. Habermalz HJ, Fischer JJ: Radiation therapy of malignant melanoma: Experience with high individual treatment doses. Cancer 1976;38:2258-2262.
14. Mazal A, Delacroix S, Arianer J, et al: Protontherapy: Physical and technical basis. Bull Cancer Radiother 1996;83:230-246.
15. Dendale R, Lumbroso-Le Rouic L, Noel G, et al: Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys 2006;65: 780-787.
16. Hamrouni Z, Levy C, Lumbroso L, et al: Results of treating uveal melanoma with proton beam radiation: 10-year follow-up. J Fr Ophtalmol 2005;28:833-839.
17. Lumbroso L, Levy C, Plancher C, et al: Results of proton beam irradiation for treatment of choroidal melanoma. J Fr Ophtalmol 2002;25:290-297.
18. Goitein M, Miller T: Planning proton therapy of the eye. Med Phys 1983;10:275-283.
19. Gragoudas ES, Lane AM, Regan S, et al: A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol 2000;118:773-778.
20. Wollensak G, Zografos L, Perret C, Egger E, Fritz-Niggli H: Experimental study on the fractionation schedule for proton irradiation of uveal melanoma. Graefes Arch Clin Exp Ophthalmol 1990;228:562-568.
21. Conway RM, Poothullil AM, Daftari IK, Weinberg V, Chung JE, O'Brien JM: Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy. Arch Ophthalmol 2006;124:838-843.
22. Desjardins L, Lumbroso L, Levy C, et al: Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: Indications and comparison of local recurrence rates. J Fr Ophtalmol 2003;26:269-276.
23. Lichter AS, Lawrence TS: Recent advances in radiation oncology. N Engl J Med 1995;332:371-379.
24. Crawford JB, Char DH: Histopathology of uveal melanomas treated with charged particle radiation. Ophthalmology 1987;94:639-643.
25. Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM: Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol 1992;110:1112-1118.
26. Chiquet C, Grange JD, Ayzac L, Chauvel P, Patricot LM, Devouassoux-Shisheboran M: Effects of proton beam irradiation on uveal melanomas: A comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas. Br J Ophthalmol 2000; 84:98-102.
27. Gragoudas ES, Egan KM, Saornil MA, Walsh SM, Albert DM, Seddon JM: The time course of irradiation changes in proton beam-treated uveal melanomas. Ophthalmology 1993;100:1555-1560.
28. Wilkes SR, Gragoudas ES: Regression patterns of uveal melanomas after proton beam irradiation. Ophthalmology 1982;89:840-844.
29. Zografos L: Tumeurs intraoculaires. Paris, Masson, 2002.
30. Boudinet M, Berges O, Le Huerou JY, Lumbroso-Le Rouic L, Desjardins L, Laugier P: Quantitative echography in the follow-up of patients treated with proton-beam irradiation for primary choroidal melanomas. Ultrasound Med Biol 2007;33:1046-1056.
31. Kaiserman I, Anteby I, Chowers I, Blumenthal EZ, Kliers I, Pe'er J: Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma. Br J Ophthalmol 2004;88:892-895.
32. Gragoudas ES, Egan KM, Seddon JM, Walsh SM, Munzenrider JE: Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 1992;99:760-766.
33. Desjardins L, Levy-Gabriel C, Lumbroso-Lerouic L, et al: Prognostic factors for malignant uveal melanoma. Retrospective study on 2,241 patients and recent contribution of monosomy-3 research. J Fr Ophtalmol 2006;29:741-749.
34. Finger PT: The 7th edition AJCC staging system for eye cancer: An international language for ophthalmic oncology. Arch Pathol Lab Med 2009;133:1197-1198.
35. Bellmann C, Lumbroso-Le Rouic L, Levy C, et al: Uveal melanoma: Management and outcome of patients with extraocular spread. Br J Ophthalmol 2010;94:569-574.
36. Egan KM, Ryan LM, Gragoudas ES: Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: An example of regression on time-dependent covariates. Arch Ophthalmol 1998;116:366-370.
37. Courdi A, Caujolle JP, Grange JD, et al: Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 1999;45:5-11.
38. Caujolle JP, Mammar H, Chamorey E, Pinon F, Herault J, Gastaud P: Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience. Int J Radiat Oncol Biol Phys 2010;78:98-103.
39. Egger E, Schalenbourg A, Zografos L, et al: Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 2001;51:138-147.
40. Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM: Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 2002;120: 1665-1671.
41. Egger E, Zografos L, Schalenbourg A, et al: Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2003;55: 867-880.
42. Ly LV, Bronkhorst IH, van Beelen E, et al: Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration. Invest;51:5445-5451.
43. Boyd SR, Gittos A, Richter M, Hungerford JL, Errington RD, Cree IA: Proton beam therapy and iris neovascularisation in uveal melanoma. Eye (Lond) 2006;20:832-836.
44. Boyd SR, Tan D, Bunce C, et al: Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: Identification of a potential therapeutic window. Br J Ophthalmol 2002;86: 448-452.
45. Missotten GS, Notting IC, Schlingemann RO, et al: Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol 2006;124:1428-1434.
46. Foss AJ, Whelehan I, Hungerford JL, et al: Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma. Br J Ophthalmol 1997;81:748-754.
47. Vasquez LM, Somani S, Altomare F, Simpson ER: Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma. Can J Ophthalmol 2009;44:106-107.
48. Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V: Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol 1995;119:157-164.
49. Merriam GR Jr, Focht EF: A clinical study of radiation cataracts and the relationship to dose. Am J Roentgenol Radium Ther Nucl Med 1957;77:759-785.
50. Hopewell JW: Radiation injury to the central nervous system. Med Pediatr Oncol 1998;Suppl 1:1-9.
51. Coderre JA, Morris GM, Micca PL, et al: Late effects of radiation on the central nervous system: Role of vascular endothelial damage and glial stem cell survival. Radiat Res 2006;166:495-503.
52. Char DH, Quivey JM, Castro JR, Kroll S, Phillips T: Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 1993;100:1547-1554.
53. Desjardins L, Lumbroso-Le Rouic L, Levy-Gabriel C, et al: Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: A randomized study of 151 patients. Ophthalmic Res 2006;38:255-260.
54. Bechrakis NE, Hocht S, Martus P, Kreusel KM, Heese J, Foerster MH: Endoresection following proton beam irradiation of large uveal melanomas. Ophthalmologe 2004;101:370-376.
55. Bechrakis NE, Foerster MH: Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin 2006;46:95-107.
56. Damato B, Groenewald C, McGalliard J, Wong D: Endoresection of choroidal melanoma. Br J Ophthalmol 1998;82:213-318.
57. Hadden PW, Hiscott PS, Damato BE: Histopathology of eyes enucleated after endoresection of choroidal melanoma. Ophthalmology 2004;111:154-160.
58. Karkhaneh R, Chams H, Amoli FA, et al: Long-term surgical outcome of posterior choroidal melanoma treated by endoresection. Retina 2007;27:908-914.